Stories about Metabolism

Subscribe to Metabolism

04.12.2020 – 12:14

Technische Universität München
WHO guidelines on physical activity call for more exercise

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.sg.tum.de/en/news-en/news-singleview-fakultaet-en/article/prof-oberhoffer-fritz-fordert-nach-aktuellen-who-empfehlungen-kinder-und-jugendliche-muessen-sich-en/ High resolution images: https://mediatum.ub.tum.de/1581167 NEWS RELEASE WHO guidelines on physical ...

more
23.11.2020 – 12:00

Fresenius Kabi Deutschland GmbH
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition

BAD HOMBURG (ots) - Evidence indicates that omega-3 (?-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty ...

more
13.11.2020 – 08:00

ForaCare Suisse AG

FORA® 6 Blood Glucose Monitors Help Diabetic Patients Monitor COVID-19 Risks

more
05.11.2020 – 16:06

Novo Nordisk A/S
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy

Bagsværd, Denmark (ots/PRNewswire) - Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP 3 phase 3a trial investigated ...

more
14.10.2020 – 12:30

Technische Universität München
An alternative to animal experiments - New applications for organoids from human intestinal tissue

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36252/ Images for journalists: https://mediatum.ub.tum.de/1576619 NEWS RELEASE New applications for organoids from human intestinal ...

more
02.09.2020 – 14:13

Technische Universität München
Finding cortisone alternatives with fewer side effects

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/die-tum/aktuelles/pressemitteilungen/details/36207/ Images for journalists: https://mediatum.ub.tum.de/1559845 NEWS RELEASE DNA binding is essential for effectiveness of steroids Finding cortisone alternatives with fewer side effects Many people use ...

more
17.08.2020 – 16:38

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

In the IZB you can find over 50 biotech start-ups
One document
more
06.08.2020 – 11:23

Technische Universität München
Grow faster, die sooner: How growth rates influence the fitness of bacteria

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36187/ High resolution images: https://mediatum.ub.tum.de/1554425 NEWS RELEASE Grow faster, die sooner How growth rates influence the fitness of bacteria ...

more
21.07.2020 – 16:00

Grünenthal Group
Grünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA® for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet

Aachen, Germany & Morristown, N.J. (ots) - - Neuropathic pain associated with diabetic peripheral neuropathy is a progressive and debilitating complication of diabetes that will affect approximately more than 5 million Americans in 20201. - QUTENZA® is the first and only topical, non-systemic, non-opioid pain ...

more
15.07.2020 – 09:51

Technische Universität München
Making balanced decisions - Neuronal circuits in the brain 'sense' our inner state

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36143/ Images for journalists: https://mediatum.ub.tum.de/1553341 NEWS RELEASE Neuronal circuits in the brain 'sense' our inner state Making balanced decisions ...

more
13.07.2020 – 20:03

Merck KGaA
Stephan Sieber Awarded EUR 1 Million Future Insight Prize 2020 by Merck

Darmstadt, Germany (ots/PRNewswire) - - Prof. Sieber is developing approaches against multi-resistant pathogens at the Technical University of Munich - Inaugural Johann Anton Merck Award presented to Prof. Caroline Dive, Cancer Research UK, for her liquid biopsy research - Sibel Health awarded the Nature Spinoff Prize Merck, a leading science and technology company, ...

more
10.06.2020 – 17:00

International Atherosclerosis Society
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk

Milan (ots/PRNewswire) - Article and slides can be found at https://www.athero.org/activities/survey or contact Karen Foy (karen.foy@athero.org) A new survey by the International Atherosclerosis Society (IAS) provided a 'snapshot' of the gaps in knowledge among clinicians that limit best practice. This web-based ...

more
13.05.2020 – 13:03

Technische Universität München
A disease trigger for pancreatitis has been identified

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36036/ High resolution images: https://mediatum.ub.tum.de/1545776 NEWS RELEASE A Calcium channel is involved in the development of pancreatitis A disease trigger for pancreatitis has been identified One factor ...

more
29.04.2020 – 10:51

Technische Universität München
Improving immunotherapy for cancer

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36023/ High resolution images: https://mediatum.ub.tum.de/1544218 NEWS RELEASE Cause for the lack of immune defense against tumors discovered Improving immunotherapy for cancer One of the reasons why cancer develops is because regulatory cells inhibit the body's ...

more
27.04.2020 – 17:22

Helmholtz Zentrum München

2
Beta cells from stem cells: Potential for cell replacement therapy

Read the study

more
15.04.2020 – 14:43

Technische Universität München
Crohn's disease: Preserving inflammation-free phases

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35979/ High resolution images: https://mediatum.ub.tum.de/1543290 NEWS RELEASE Early detection of Crohn’s disease flare-ups leads to improved therapy options Preserving inflammation-free phases Crohn’s ...

more
31.03.2020 – 18:00

Novo Nordisk A/S
Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged ...

more
26.03.2020 – 15:41

APR
FDA Grants Orphan Drug Designation to APR-OD031 for the Treatment of Phenylketonuria (PKU)

Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research s.a. ("APR"), the Swiss pharma company leveraging drug delivery technologies to develop innovative products for niche and rare diseases, today announced that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for the treatment ...

more
17.02.2020 – 10:00

Fresenius Kabi Deutschland GmbH
A new expert consensus publication provides practical guidance on the use of omega-3 fatty acids in parenteral nutrition

Bad Homburg (ots) - Fresenius Kabi, a global leader in clinical nutrition, announces that the Journal of Parenteral and Enteral Nutrition (JPEN) has recently published "Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice".(1) The publication represents the largest set of expert consensus ...

more
09.01.2020 – 09:03

Technische Universität München
Gene network helps to turn white fat into beneficial calorie burning fat

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/ High resolution images: https://mediatum.ub.tum.de/1524726 NEWS RELEASE A new approach to treating overweight and obesity Gene network helps to turn white fat into beneficial calorie ...

more
16.12.2019 – 17:07

Technische Universität München
From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...

more
04.12.2019 – 12:22

APR Applied Pharma Research s.a.
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa

Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for its investigational drug code-named APR-TD011 for treatment of ...

more
25.10.2019 – 10:03

Helmholtz Zentrum München

Helmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes

Learn more about Helmholtz Zentrum München

more
21.10.2019 – 17:03

Helmholtz Zentrum München

Identification of a ferroptosis suppressor protein allows for new anticancer treatment approach

Read more about Helmholtz Zentrum München

more
14.10.2019 – 17:27

Helmholtz Zentrum München

Discovery of potential novel therapeutic target for non-alcoholic fatty liver disease

Read the paper

more
04.10.2019 – 11:05

Technische Universität München
Weak spot in pathogenic bacteria: ClpX-ClpP protein complex could be starting point for new antibiotics

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35720/ High resolution images: https://mediatum.ub.tum.de/1520810 NEWS RELEASE Weak spot in pathogenic bacteria ClpX-ClpP protein complex could be starting ...

more
17.09.2019 – 15:45

Novo Nordisk A/S
Ozempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes

Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk announced today the results from two Ozempic® (once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed: - Ozempic® was superior to treatment with the SGLT-2 inhibitor canagliflozin (300 mg) in reducing HbA1c and ...

more
05.08.2019 – 13:12

Technische Universität München
Dry feed for superfood producers: study investigates nutritional behavior of insects

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10516 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35635/ High resolution pictures: https://mediatum.ub.tum.de/1516504 NEWS RELEASE International study investigates nutritional behavior of insects Dry feed ...

more
02.07.2019 – 15:27

artgerecht GmbH

Word Weer Mens - Cookbook, Specialist Book, Health Book ... and Much More

more
11.06.2019 – 12:00

APR Applied Pharma Research s.a.
29th EWMA Conference: Latest Clinical Data on Nexodyn® AOS Demonstrating Higher Healing Performance in Chronic Leg Ulcers Presented by Applied Pharma Research

Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the results of a clinical study confirming Nexodyn® AcidOxidizing Solution (AOS) to promote the restart of the healing process in ...

more

12Next